메뉴 건너뛰기




Volumn 13, Issue 4, 2013, Pages 342-348

Global economic burden of Chagas disease: A computational simulation model

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CHAGAS DISEASE; CONGESTIVE HEART FAILURE; DEATH; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; HEALTH CARE COST; HUMAN; INFECTION CONTROL; PRIORITY JOURNAL; PROBABILITY; SIMULATION; UNITED STATES;

EID: 84875614866     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70002-1     Document Type: Article
Times cited : (482)

References (36)
  • 1
    • 41949089967 scopus 로고    scopus 로고
    • Mother-to-child transmission of Chagas' disease in North America: why don't we do more?
    • Buekens P, Almendares O, Carlier Y, et al. Mother-to-child transmission of Chagas' disease in North America: why don't we do more?. Matern Child Health J 2008, 12:283-286.
    • (2008) Matern Child Health J , vol.12 , pp. 283-286
    • Buekens, P.1    Almendares, O.2    Carlier, Y.3
  • 2
    • 84863218306 scopus 로고    scopus 로고
    • Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain)
    • Barona-Vilar C, Gimenez-Marti MJ, Fraile T, et al. Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain). Epidemiol Infect 2012, 140:1896-1903.
    • (2012) Epidemiol Infect , vol.140 , pp. 1896-1903
    • Barona-Vilar, C.1    Gimenez-Marti, M.J.2    Fraile, T.3
  • 4
    • 54149090275 scopus 로고    scopus 로고
    • World Health Organization, World Health Organization, Geneva
    • The Global Burden of Disease 2004 Update 2008, World Health Organization, World Health Organization, Geneva.
    • (2008) The Global Burden of Disease 2004 Update
  • 6
    • 78650707764 scopus 로고    scopus 로고
    • The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America
    • Lee BY, Bacon KM, Connor DL, Willig AM, Bailey RR The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America. PLoS Negl Trop Dis 2010, 4:e916.
    • (2010) PLoS Negl Trop Dis , vol.4
    • Lee, B.Y.1    Bacon, K.M.2    Connor, D.L.3    Willig, A.M.4    Bailey, R.R.5
  • 9
    • 84873065422 scopus 로고    scopus 로고
    • Clinical and epidemiolgical characteristics of patients with Chagas' disease submitted to permanent cardiac pacemaker implantation
    • Costa R, Rassi A, Leao M Clinical and epidemiolgical characteristics of patients with Chagas' disease submitted to permanent cardiac pacemaker implantation. Rev Bras Cir Cardiovasc 2004, 19:107-114.
    • (2004) Rev Bras Cir Cardiovasc , vol.19 , pp. 107-114
    • Costa, R.1    Rassi, A.2    Leao, M.3
  • 10
    • 17544400692 scopus 로고    scopus 로고
    • Long term evaluation of etiological treatment of Chagas disease with benznidazole
    • Cancado JR Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop Sao Paulo 2002, 44:29-37.
    • (2002) Rev Inst Med Trop Sao Paulo , vol.44 , pp. 29-37
    • Cancado, J.R.1
  • 13
    • 36348949834 scopus 로고    scopus 로고
    • Epidemiology of Chagas disease in non-endemic countries: the role of international migration
    • Schmunis GA Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007, 102(suppl 1):75-85.
    • (2007) Mem Inst Oswaldo Cruz , vol.102 , Issue.SUPPL. 1 , pp. 75-85
    • Schmunis, G.A.1
  • 14
    • 77953028103 scopus 로고    scopus 로고
    • Chagas disease: a Latin American health problem becoming a world health problem
    • Schmunis GA, Yadon ZE Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010, 115:14-21.
    • (2010) Acta Trop , vol.115 , pp. 14-21
    • Schmunis, G.A.1    Yadon, Z.E.2
  • 15
    • 80053066448 scopus 로고    scopus 로고
    • Chagas disease in Italy: breaking an epidemiological silence
    • Angheben A, Anselmi M, Gobbi F, et al. Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill 2011, 16:6-13.
    • (2011) Euro Surveill , vol.16 , pp. 6-13
    • Angheben, A.1    Anselmi, M.2    Gobbi, F.3
  • 16
    • 80053069779 scopus 로고    scopus 로고
    • EuroTravNet: imported Chagas disease in nine European countries: 2008 to 2009
    • Perez-Molina JA, Perez-Ayala A, Parola P, et al. EuroTravNet: imported Chagas disease in nine European countries: 2008 to 2009. Euro Surveill 2011, 16:52-56.
    • (2011) Euro Surveill , vol.16 , pp. 52-56
    • Perez-Molina, J.A.1    Perez-Ayala, A.2    Parola, P.3
  • 17
    • 80053090538 scopus 로고    scopus 로고
    • Chagas disease in Switzerland: history and challenges
    • pii 19963.
    • Jackson Y, Chappuis F Chagas disease in Switzerland: history and challenges. Euro Surveill 2011, 16. pii 19963.
    • (2011) Euro Surveill , vol.16
    • Jackson, Y.1    Chappuis, F.2
  • 18
    • 80053930256 scopus 로고    scopus 로고
    • Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010
    • Navarro M, Perez-Ayala A, Guionnet A, et al. Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010. Euro Surveill 2011, 16:41-45.
    • (2011) Euro Surveill , vol.16 , pp. 41-45
    • Navarro, M.1    Perez-Ayala, A.2    Guionnet, A.3
  • 19
    • 80053082551 scopus 로고    scopus 로고
    • Chagas disease in European countries: the challenge of a surveillance system
    • pii 19968.
    • Basile L, Janso JM, Carlier Y, et al. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill 2011, 16. pii 19968.
    • (2011) Euro Surveill , vol.16
    • Basile, L.1    Janso, J.M.2    Carlier, Y.3
  • 22
    • 0021802886 scopus 로고
    • Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983)
    • Espinosa R, Carrasco HA, Belandria F, et al. Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983). Int J Cardiol 1985, 8:45-56.
    • (1985) Int J Cardiol , vol.8 , pp. 45-56
    • Espinosa, R.1    Carrasco, H.A.2    Belandria, F.3
  • 23
    • 65649128606 scopus 로고    scopus 로고
    • The costs of preventing and treating Chagas disease in Colombia
    • Castillo-Riquelme M, Guhl F, Turriago B, et al. The costs of preventing and treating Chagas disease in Colombia. PLoS Negl Trop Dis 2008, 2:e336.
    • (2008) PLoS Negl Trop Dis , vol.2
    • Castillo-Riquelme, M.1    Guhl, F.2    Turriago, B.3
  • 25
    • 84875578017 scopus 로고    scopus 로고
    • Center for Biosecurity of UPMC, (accessed July 10, 2012).
    • Infectious disease cost calculator Center for Biosecurity of UPMC, (accessed July 10, 2012). http://www.idcostcalc.org/Hold_May2012/about/cost-of-ID.html.
    • Infectious disease cost calculator
  • 26
    • 77954526124 scopus 로고    scopus 로고
    • Rotavirus infections and vaccines: burden of illness and potential impact of vaccination
    • Grimwood K, Lambert SB, Milne RJ Rotavirus infections and vaccines: burden of illness and potential impact of vaccination. Paediatr Drugs 2010, 12:235-256.
    • (2010) Paediatr Drugs , vol.12 , pp. 235-256
    • Grimwood, K.1    Lambert, S.B.2    Milne, R.J.3
  • 27
    • 84871099014 scopus 로고    scopus 로고
    • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
    • Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
    • (2012) Lancet , vol.380 , pp. 2197-2223
    • Murray, C.J.1    Vos, T.2    Lozano, R.3
  • 28
    • 0032038615 scopus 로고    scopus 로고
    • Why companies should intervene: a case study of the costs of HIV/AIDs to employers. Economic impact: Southern Africa
    • Greener R Why companies should intervene: a case study of the costs of HIV/AIDs to employers. Economic impact: Southern Africa. AIDS Anal Afr 1998, 8:3-4.
    • (1998) AIDS Anal Afr , vol.8 , pp. 3-4
    • Greener, R.1
  • 29
    • 0033867599 scopus 로고    scopus 로고
    • Care and treatment to extend the working lives of HIV-positive employees: calculating the benefits to business
    • Rosen S, Simon JL, Thea DM, Vincent JR Care and treatment to extend the working lives of HIV-positive employees: calculating the benefits to business. South Afr J Sci 2000, 96:3000-3004.
    • (2000) South Afr J Sci , vol.96 , pp. 3000-3004
    • Rosen, S.1    Simon, J.L.2    Thea, D.M.3    Vincent, J.R.4
  • 30
    • 77953023715 scopus 로고    scopus 로고
    • Chagas disease in Spain, the United States and other non-endemic countries
    • Gascon J, Bern C, Pinazo MJ Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010, 115:22-27.
    • (2010) Acta Trop , vol.115 , pp. 22-27
    • Gascon, J.1    Bern, C.2    Pinazo, M.J.3
  • 31
    • 84865733448 scopus 로고    scopus 로고
    • The United States Trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors
    • Cantey PT, Stramer SL, Townsend RL, et al. The United States Trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 2012, 52:1922-1930.
    • (2012) Transfusion , vol.52 , pp. 1922-1930
    • Cantey, P.T.1    Stramer, S.L.2    Townsend, R.L.3
  • 32
    • 0031729329 scopus 로고    scopus 로고
    • A cost-of-illness study of Lyme disease in the United States
    • Maes E, Lecomte P, Ray N A cost-of-illness study of Lyme disease in the United States. Clin Ther 1998, 20:993-1008.
    • (1998) Clin Ther , vol.20 , pp. 993-1008
    • Maes, E.1    Lecomte, P.2    Ray, N.3
  • 33
    • 84876803243 scopus 로고    scopus 로고
    • The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
    • published online May 21.
    • Lee BY, Singh A, David MZ, et al. The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clin Microbiol Infect 2012, published online May 21. 10.1111/j.1469-0691.2012.03914.x.
    • (2012) Clin Microbiol Infect
    • Lee, B.Y.1    Singh, A.2    David, M.Z.3
  • 35
    • 33644848293 scopus 로고    scopus 로고
    • Screening the United States blood supply for West Nile virus: a question of blood, dollars, and sense
    • Lee BY, Biggerstaff BJ Screening the United States blood supply for West Nile virus: a question of blood, dollars, and sense. PLoS Med 2006, 3:e99.
    • (2006) PLoS Med , vol.3
    • Lee, B.Y.1    Biggerstaff, B.J.2
  • 36
    • 42549167183 scopus 로고    scopus 로고
    • Digital decision making: computer models and antibiotic prescribing in the twenty-first century
    • Lee BY Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis 2008, 46:1139-1141.
    • (2008) Clin Infect Dis , vol.46 , pp. 1139-1141
    • Lee, B.Y.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.